Activation of rat mesenteric arterial KATP channels by 11,12-epoxyeicosatrienoic acid

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 1 57-1, 2005, Pages

  Ye, Dan ^a   Zhou, Wei ^a   Lee, Hon Chi ^a  

^a MAYO CLINIC   (United States)

Author keywords

ATP sensitive K+ channel; Mesenteric artery; Protein kinase A

Indexed keywords

11,12 EPOXY 5,8,14 ICOSATRIENOIC ACID; ADENOSINE TRIPHOSPHATE; ARACHIDONIC ACID DERIVATIVE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; GLIBENCLAMIDE; ICOSATRIENOIC ACID; INHIBITOR PROTEIN; PEPTIDE; PINACIDIL; POTASSIUM CHANNEL; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; MALE; MESENTERIC ARTERY; NONHUMAN; PATCH CLAMP; PIPETTE; PRIORITY JOURNAL; RAT; RAT STRAIN; VASODILATATION;

8,11,14-EICOSATRIENOIC ACID; ADENOSINE TRIPHOSPHATE; ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; MESENTERIC ARTERIES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; POTASSIUM CHANNELS; RATS; VASODILATION; VASODILATOR AGENTS;

EID: 11144287211     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00423.2004     Document Type: Article

References (42)

1. Aguilar-Bryan L and Bryan J. Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr Rev 20: 101-135, 1999.
2. Alkayed NJ, Goyagi T, Joh HD, Klaus J, Harder DR, Traystman RJ, and Hurn PD. Neuroprotection and P450 2C11 upregulation after experimental transient ischemic attack. Stroke 33: 1677-1684, 2002.
3. ATP channels in vascular smooth muscle. Clin Exp Pharmacol Physiol 29: 312-316, 2002.
4. Campbell WB, Gebremedhin D, Pratt PF, and Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78: 415-423, 1996.
5. Campbell WB and Harder DR. Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone. Circ Res 84: 484-488, 1999.
6. Chen J, Capdevila JH, Zeldin DC, and Rosenberg RL. Inhibition of cardiac L-type calcium channels by epoxyeicosatrienoic acids. Mol Pharmacol 55: 288-295, 1999.
7. + channel-mediated responses of the basilar artery. Stroke 33: 1692-1697, 2002.
8. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, and Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401: 493-497, 1999.
9. Fukao M, Hattori Y, Kanno M, Sakuma I, and Kitabatake A. Evidence against a role of cytochrome P450-derived arachidonic acid metabolites in endothelium-dependent hyperpolarization by acetylcholine in rat isolated mesenteric artery. Br J Pharmacol 120: 439-446, 1997.
10. ATP channels by inhibiting steady-state protein kinase A activity and activating protein kinase Cε. J Physiol 530: 193-205, 2001.
11. + current in human and rabbit ventricular myocytes. Circ Res 78: 492-498, 1996.
12. Imig JD, Inscho EW, Deichmann PC, Reddy KM, and Falck JR. Afferent arteriolar vasodilation to the sulfonimide analog of 11,12-epoxyeicosatrienoic acid involves protein kinase A. Hypertension 33: 408-413, 1999.
13. + currents in rat arterial smooth muscle cells through protein kinase C. J Physiol 503: 489-496, 1997.
14. Lee H, Lu T, Weintraub NL, VanRollins M, Spector AA, and Shibata EF. Effects of epoxyeicosatrienoic acids on the cardiac sodium channels in isolated rat ventricular myocytes. J Physiol 519: 153-168, 1999.
15. Light PE, Bladen C, Winkfein RJ, Walsh MP, and French RJ. Molecular basis of protein kinase C-induced activation of ATP-sensitive potassium channels. Proc Natl Acad Sci USA 97: 9058-9063, 2000.
16. Lin YF, Jan YN, and Jan LY. Regulation of ATP-sensitive potassium channel function by protein kinase A-mediated phosphorylation in transfected HEK293 cells. EMBO J 19: 942-955, 2000.
17. + channels by epoxyeicosatrienoic acids in rat cardiac ventricular myocytes. J Physiol 537: 811-827, 2001.
18. + channels in isolated rat coronary arterial myocytes. J Physiol 534: 651-667, 2001.
19. + channels by epoxyeicosatrienoic acids: a structural determinant study. Mol Pharmacol 62: 1076-1083, 2002.
20. McGiff JC. Cytochrome P-450 metabolism of arachidonic acid. Annu Rev Pharmacol Toxicol 31: 339-369, 1991.
21. Miki T, Suzuki M, Shibasaki T, Uemura H, Sato T, Yamaguchi K, Koseki H, Iwanaga T, Nakaya H, and Seino S. Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1. Nat Med 8: 466-472, 2002.
22. Miller AW, Dimitropoulou C, Han G, White RE, Busija DW, and Carrier GO. Epoxyeicosatrienoic acid-induced relaxation is impaired in insulin resistance. Am J Physiol Heart Circ Physiol 281: H1524-H1531, 2001.
23. + channels. Circ Res 83: 501-507, 1998.
24. Miura H, Wachtel RE, Loberiza FR Jr, Saito T, Miura M, Nicolosi AC, and Gutterman DD. Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles: reduced activity of ATP-sensitive potassium channels. Circ Res 92: 151-158, 2003.
25. Nithipatikom K, DiCamelli RF, Kohler S, Gumina RJ, Falck JR, Campbell WB, and Gross GJ. Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs. Anal Biochem 292: 115-124, 2001.
26. Quayle JM, Nelson MT, and Standen NB. ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev 77: 1165-1232, 1997.
27. - channel activity by 5,6- and 11,12-EET. Am J Physiol Lung Cell Mol Physiol 275: L432-L441, 1998.
28. ATP channels in the pancreas and cardiovascular system: a review. J Diabetes Complications 17: 2-5, 2003.
29. + channels. Jpn J Physiol 47, Suppl 1: S3-S4, 1997.
30. + channels. Prog Biophys Mol Biol 81: 133-176, 2003.
31. Suzuki M, Li RA, Miki T, Uemura H, Sakamoto N, Ohmoto-Sekine Y, Tamagawa M, Ogura T, Seino S, Marban E, and Nakaya H. Functional roles of cardiac and vascular ATP-sensitive potassium channels clarified by Kir6.2-knockout mice. Circ Res 88: 570-577, 2001.
32. ATP channels in cardioprotection against ischemia/reperfusion injury in mice. J Clin Invest 109: 509-516, 2002.
33. + channel activation by calcitonin gene-related peptide and protein kinase A in pig coronary arterial smooth muscle. J Physiol 507: 117-129, 1998.
34. 2+ channels and contraction in mammalian heart cells. J Physiol 508: 777-792, 1998.
35. Yang B, Graham L, Dikalov S, Mason RP, Falck JR, Liao JK, and Zeldin DC. Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells. Mol Pharmacol 60: 310-320, 2001.
36. Ye D, Zhang D, Oltman C, Dellsperger K, Lee HC, and VanRollins M. Cytochrome p-450 epoxygenase metabolites of docosanexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels. J Pharmacol Exp Ther 303: 768-776, 2002.
37. + channels in pancreatic, cardiac, and vascular smooth muscle cells. Am J Physiol Cell Physiol 274: C25-C37, 1998.
38. Zeldin DC. Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 276: 36059-36062, 2001.
39. Zhang Y, Cribbs LL, and Satin J. Arachidonic acid modulation of α1H, a cloned human T-type calcium channel. Am J Physiol Heart Circ Physiol 278: H184-H193, 2000.
40. Ca channels. Am J Physiol Heart Circ Physiol 280: H2430-H2440, 2001.
41. Zingman LV, Hodgson DM, Bast PH, Kane GC, Perez-Terzic C, Gumina RJ, Pucar D, Bienengraeber M, Dzeja PP, Miki T, Seino S, Alekseev AE, and Terzic A. Kir6.2 is required for adaptation to stress. Proc Natl Acad Sci USA 99: 13278-13283, 2002.
42. + channel activity. Am J Physiol Renal Fluid Electrolyte Physiol 270: F822-F832, 1996.